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Abstract. We performed an exome-wide association study 
(EWAS) to identify genetic variants - in particular, low-frequency 
or rare variants with a moderate to large effect size - that confer 
susceptibility to aortic aneurysm with 8,782 Japanese subjects 
(456 patients with aortic aneurysm, 8,326 control individuals) 
and with the use of Illumina HumanExome-12 DNA Analysis 
BeadChip or Infinium Exome-24 BeadChip arrays. The 
correlation of allele frequencies for 41,432 single nucleotide 
polymorphisms (SNPs) that passed quality control to aortic 
aneurysm was examined with Fisher's exact test. Based on 
Bonferroni's correction, a P-value of <1.21x10-6 was considered 
statistically significant. The EWAS revealed 59 SNPs that were 
significantly associated with aortic aneurysm. None of these 
SNPs was significantly (P<2.12x10-4) associated with aortic 
aneurysm by multivariable logistic regression analysis with 
adjustment for age, gender and hypertension, although 8 SNPs 
were related (P<0.05) to this condition. Examination of the 
correlation of these latter 8 SNPs to true or dissecting aortic 
aneurysm separately showed that rs1465567 [T/C (W229R)] 
of the EGF-like, fibronectin type III, and laminin G domains 
gene (EGFLAM) (dominant model; P=0.0014; odds ratio, 
1.63) was significantly (P<0.0016) associated with true aortic 
aneurysm. We next performed EWASs for true or dissecting 
aortic aneurysm separately and found that 45 and 19 SNPs were 
significantly associated with these conditions, respectively. 
Multivariable logistic regression analysis with adjustment for 
covariates revealed that rs113710653 [C/T (E231K)] of the sper-
matogenesis- and centriole associated 1-like gene (SPATC1L) 
(dominant model; P=0.0002; odds ratio, 5.32) and rs143881017 
[C/T (R140H)] of the ribonuclease A family member 13 gene 
(RNASE13) (dominant model; P=0.0006; odds ratio, 5.77) were 
significantly (P<2.78x10-4 or P<6.58x10-4, respectively) asso-
ciated with true or dissecting aortic aneurysm, respectively. 
EGFLAM and SPATC1L may thus be susceptibility loci for 
true aortic aneurysm and RNASE13 may be such a locus for 
dissecting aneurysm in Japanese individuals.
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Introduction
Aortic aneurysm is a serious condition that results from an 
atherosclerotic aorta and is a leading cause of mortality in 
humans (1). Studies on the genetic basis of familial aortic 
aneurysm have centered on the relationship between the condi-
tion to systemic connective tissue disorders such as Marfan 
syndrome (2) and Ehlers-Danlos syndrome (3). Although the 
molecular mechanism underlying nonsyndromic aortic aneu-
rysm is complex and has not been determined definitively, 
several risk factors, including age, arteriosclerosis, hyperten-
sion and inflammatory or autoimmune diseases that affect the 
aorta, have been identified clinically (4,5). In addition to these 
conventional risk factors, recent studies have shown the impor-
tance of genetic factors in the development of sporadic aortic 
aneurysm by revealing a heritability of ~70% (6). Genome-
wide association studies (GWASs) have uncovered several 
loci and genes that confer susceptibility to aortic aneurysm in 
European ancestry populations (7-12), but genetic variants that 
contribute to the development of this condition in Japanese 
individuals have not been identified definitively.
Genetic variants previously associated with aortic aneu-
rysm typically have a minor allele frequency (MAF) of >10% 
and a small individual effect size (7-12). Given that these 
common variants explain only a small fraction of disease 
heritability, low-frequency (MAF of 0.5-5%) or rare (MAF 
of <0.5%) variants with a larger effect size may contribute to 
the genetic architecture of aortic aneurysm (13).
In the present study, we performed exome-wide association 
studies (EWASs) with the use of exome array-based genotyping 
methods to identify single nucleotide polymorphisms (SNPs) 
- in particular, low-frequency or rare coding variants with a 
moderate to large effect size - that confer susceptibility to 
aortic aneurysm in Japanese individuals. Given that most 
low-frequency or rare variants were not included in the arrays 
of previous GWASs, we used Illumina HumanExome-12 
DNA Analysis BeadChip or Infinium Exome-24 BeadChip 
arrays, which provide coverage for functional SNPs including 
low-frequency or rare variants in entire exons.
Materials and methods
Study population. A total of 8,782 Japanese individuals 
(456 patients with aortic aneurysm, 8,326 controls) was 
examined. The subjects were recruited from individuals who 
visited outpatient clinics of or were admitted to participating 
hospitals (Gifu Prefectural Tajimi Hospital, Tajimi; Gifu 
Prefectural General Medical Center, Gifu; Japanese Red 
Cross Nagoya First Hospital, Nagoya; Inabe General Hospital, 
Inabe; Hirosaki University Hospital and Hirosaki Stroke 
and Rehabilitation Center, Hirosaki) either because they 
were experiencing various symptoms or for an annual health 
checkup between 2002 and 2014; from community-dwelling 
individuals recruited to a population-based cohort study in 
Inabe between 2010 and 2014 or in Tokyo or Kusatsu between 
2011 and 2015; or from individuals who underwent autopsy 
at Tokyo Metropolitan Geriatric Hospital from 1995 to 2012.
True aortic aneurysm was defined as a permanent localized 
dilation of the aorta with a ≥50% increase in diameter relative 
to the expected normal size of the artery or with a diameter 
of >5 cm (14). Dissecting aortic aneurysm was defined as 
separation of the aortic wall layers with resulting true and 
false lumens or as intramural hematoma (15). The subjects 
with aortic aneurysm (279 with true aneurysm and 181 with 
dissecting aneurysm (four had both conditions) were examined 
by chest and abdominal X-ray and echocardiography followed 
by contrast medium-enhanced computed tomography. Some 
subjects were also examined by aortic angiography. Individuals 
with Marfan syndrome, Ehlers-Danlos syndrome, bicuspid 
aortic valve disease, aortitis syndrome, connective tissue 
disorder, congenital malformations of the heart or vessels, 
pseudoaneurysm, or traumatic aneurysm were excluded from 
the study. The control individuals had no history of aortic, 
coronary, or peripheral arterial disease; ischemic or hemor-
rhagic stroke; intracranial aneurysm; or other atherosclerotic, 
thrombotic, embolic or hemorrhagic disorders. Autopsy cases 
without aortic aneurysm were excluded from controls.
The study protocol complied with the Declaration of 
Helsinki and was approved by the Committees on the Ethics 
of Human Research of Mie University Graduate School of 
Medicine, Hirosaki University Graduate School of Medicine, 
Tokyo Metropolitan Institute of Gerontology, and participating 
hospitals. Written informed consent was obtained from each 
participant or from families of the deceased subjects.
EWASs. Venous blood (5 or 7 ml) was collected into tubes 
containing 50 mmol/l ethylenediaminetetraacetic acid (diso-
dium salt), peripheral blood leukocytes were isolated, and 
genomic DNA was extracted from these cells either with the 
use of a DNA extraction kit (Genomix supplied by Talent, 
Trieste, Italy, or SMITEST EX-R&D supplied by Medical 
and Biological Laboratories, Nagoya, Japan) or by standard 
protocols based on phenol-chloroform extraction and spin 
columns. In autopsy cases, genomic DNA was extracted from 
kidneys. EWASs were performed for the 456 subjects with 
aortic aneurysm (or for the 279 subjects with true aneurysm 
or 181 subjects with dissecting aneurysm) and the 8,326 
control subjects with the use of a HumanExome-12 v1.1 or 
v1.2 DNA Analysis BeadChip or an Infinium Exome-24 v1.0 
BeadChip (Illumina, San Diego, CA, USA). These exome 
arrays include putative functional exonic variants selected 
from >12,000 individual exome or whole-genome sequences. 
The exonic content consists of ~244,000 SNPs representing 
diverse populations, including European, African, Chinese 
and Hispanic individuals (16). SNPs contained in only one of 
the exome arrays (~3.6%) were excluded from analysis. We 
performed quality control (17) as follows. i) Genotyping data 
with a call rate of <97% were discarded, with the mean call 
rate for the remaining data being 99.9%. ii) Gender specifica-
tion was checked for each sample, with samples for which the 
gender designation in the clinical records was inconsistent 
with genetic sex being discarded. iii) Duplicated samples and 
cryptic relatedness were checked by calculation of identity 
by descent; all pairs with DNA samples showing identity by 
descent of >0.1875 were inspected and one sample from each 
pair was excluded. iv) The frequency of heterozygosity of 
SNPs was calculated for all samples, with those found to have 
extremely low or high heterozygosity (>3 standard deviations 
from the mean) being discarded. v) SNPs in sex chromosomes 
or mitochondrial DNA were excluded from the analysis, as 
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were nonpolymorphic SNPs or SNPs with a MAF of <0.1%. 
vi) SNPs whose genotype distributions in control individuals 
deviated significantly (P<0.001) from Hardy-Weinberg 
equilibrium were excluded. vii) The genotype data for each 
EWAS were examined for population stratification by prin-
cipal components analysis (18), and population outliers were 
excluded from the analysis. A total of 41,432 SNPs passed 
quality control and was subjected to analysis.
Statistical analysis. Quantitative data for characteristics of the 
study subjects were compared between patients with aortic 
aneurysm and control individuals with the unpaired Student's 
t test. Categorical data were compared between the two groups 
with Fisher's exact test. Allele frequencies were estimated by 
the gene counting method, and Fisher's exact test was applied 
to identify departure from Hardy-Weinberg equilibrium. 
Allele frequencies of SNPs were compared between patients 
with aortic aneurysm and control subjects with Fisher's exact 
test. Multivariable logistic regression analysis was performed 
with aortic aneurysm as a dependent variable and indepen-
dent variables including age, gender (0, woman; 1, man), the 
prevalence of hypertension (0, no history of this condition; 
1, positive history), and genotype of each SNP. Genotypes of 
SNPs were assessed according to dominant [0, AA; 1, AB+BB 
(A, major allele; B, minor allele)], recessive (0, AA+AB; 
1, BB), and additive genetic models, and the P-value, odds 
ratio, and 95% confidence interval were calculated. Additive 
models comprised additive 1 (0, AA; 1, AB; 0, BB) and addi-
tive 2 (0, AA; 0, AB; 1, BB) models, which were analyzed 
simultaneously with a single statistical model. To compensate 
for multiple comparisons of genotypes with aortic aneurysm, 
we applied Bonferroni's correction for statistical significance 
of association. Given that 41,432 SNPs were finally examined, 
a P-value of <1.21x10-6 (0.05/41,432) was considered statisti-
cally significant. A quantile-quantile plot for P-values of 
allele frequencies in the EWAS for aortic aneurysm is shown 
in Fig. 1. The inflation factor (λ) was 1.57. P-values for other 
comparisons were similarly adjusted by Bonferroni's correc-
tion. Statistical tests were performed with JMP Genomics 
version 6.0 software (SAS Institute, Cary, NC, USA).
Results
Characteristics of the subjects. The characteristics of the 
subjects enrolled in the study are shown in Table I. Age, 
the frequency of males, and the prevalence of hypertension, 
diabetes mellitus, dyslipidemia, chronic kidney disease and 
hyperuricemia were significantly greater in patients with 
aortic aneurysm than in control individuals.
EWAS of aortic aneurysm. We examined the correlation of 
allele frequencies for 41,432 SNPs that passed quality control 
to aortic aneurysm using the Fisher's exact test. A Manhattan 
plot for the EWAS of aortic aneurysm is shown in Fig. 2. After 
Bonferroni's correction, 59 SNPs were found to be significantly 
(P<1.21x10-6) associated with aortic aneurysm (Table II). The 
genotype distributions of these SNPs were in Hardy-Weinberg 
equilibrium (P>0.001) both among patients with aortic aneu-
rysm and among the control individuals (data not shown).
Multivariable logistic regression analysis of the correlation 
of SNPs to aortic aneurysm. The relation of the 59 identi-
fied SNPs to aortic aneurysm was examined further by 
multivariable logistic regression analysis with adjustment for 
age, gender and the prevalence of hypertension. Although 8 
SNPs were related (P<0.05) to aortic aneurysm, no SNP was 
significantly [P<2.12x10-4 (0.05/236)] associated with this 
condition (Table III). We then examined the correlation of 
the 8 identified SNPs to true or dissecting aortic aneurysm 
separately. Five SNPs were related (P<0.05) to true aortic 
aneurysm (Table IV), among which rs1465567 [T/C (W229R)] 
of EGF-like, fibronectin type III, and laminin G domains gene 
(EGFLAM) was significantly [P<0.0016 (0.05/32)] associated 
with this condition, with the minor C allele representing a risk 
Figure 1. Quantile-quantile plot for P-values of allele frequencies in the 
exome-wide association study (EWAS) of aortic aneurysm. The observed 
P-values (y-axis) are compared with the expected P-values (x-axis) under the 
null hypothesis, with the values being plotted as -log10(P).
Table I. Characteristics of the 8,782 study subjects.
 Aortic
Characteristics aneurysm Control P-value
No. of subjects 456 8326
Age (years) 74.7±13.5 57.3±13.5 <0.0001
Gender (male/female, %) 64.0/36.0 51.4/48.6 <0.0001
Body mass index (kg/m2) 23.2±3.5 23.1±3.5 0.7068
Current or former smoker (%) 44.1 39.8 0.1777
Hypertension (%) 94.5 40.7 <0.0001
Diabetes mellitus (%) 44.7 14.7 <0.0001
Dyslipidemia (%) 67.9 56.8 0.0006
Chronic kidney disease (%) 41.9 17.5 <0.0001
Hyperuricemia (%) 25.7 16.1 0.0003
Quantitative data are expressed as means ± SD and were compared 
between patients with aortic aneurysm and control individuals with 
the unpaired Student's t-test. Categorical data were compared with 
Fisher's exact test. Based on Bonferroni's correction, a P-value of 
<0.0056 (0.05/9) was considered statistically significant.
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Table II. The 59 single nucleotide polymorphisms (SNPs) significantly (P<1.21x10-6) associated with aortic aneurysm in an 
exome-wide association study (EWAS).
  Nucleotide
  (amino acid) Chromosome: MAF P-value Allele
Gene dbSNP substitutiona position (%) (allele) OR
CATSPER4 rs11247866 A/G (Q77R) 1:26191303 0.4 9.82x10-147 1.81
RNASE13 rs143881017 C/T (R140H) 14:21033870 0.5 2.49x10-144 2.77
RNASE10 rs202109789 G/A (G87S) 14:20510730 0.2 4.32x10-123 0.47
 rs2582513 A/G 14:104948453 39.9 1.72x10-118 0.86
HEATR1 rs193150310 T/A (V1975D) 1:236554752 0.3 3.09x10-118 0.76
KIAA1217 rs10828663 G/A (A807T) 10:24524525 10.4 2.68x10-100 1.00
MTUS1 rs3739407 G/A (R148C) 8:17755366 38.4 2.32x10-87 0.98
OR5W2 rs75634103 G/A 11:55914523 10.4 2.74x10-87 1.11
ALPK1 rs2074379 A/G (I732M) 4:112431743 32.0 1.03x10-86 1.11
ATAD5 rs11657270 T/C (Y1419H) 17:30887369 18.1 3.24x10-64 1.13
ACAT2 rs25683 A/G (K211R) 6:159775311 18.8 1.90x10-61 0.86
ZNF474 rs201335566 G/A (R253Q) 5:122152748 0.5 4.22x10-44 1.29
ZNF804B rs6963781 A/G (M1105V) 7:89336295 5.1 1.85x10-42 0.90
LOC100506679 rs5751416 G/A 22:43036820 26.3 1.62x10-41 0.81
SSPO rs191064068 G/A (R209H) 7:149777738 1.1 8.55x10-35 1.13
ARHGEF28 rs536568 A/C 5:73935841 45.8 3.61x10-33 1.03
TMEM2 rs142154818 G/A (T1062M) 9:71700645 1.0 6.41x10-33 1.90
HLA-DMB rs151719 A/G 6:32936123 25.7 1.11x10-30 1.03
CCDC66 rs61747994 T/C (L802S) 3:56619399 9.8 3.77x10-30 0.92
 rs3135365 T/G 6:32421478 18.9 1.62x10-28 0.84
NAA25 rs12231744 C/T (R876K) 12:112039251 35.1 5.02x10-28 1.07
RALGAPA2 rs142962992 G/C (E1676D) 20:20505435 0.9 1.77x10-26 1.10
NEU1 rs13118 T/A 6:31859509 9.7 6.92x10-22 1.20
AXDND1 rs41267592 C/T (T627M) 1:179468524 0.3 1.42x10-20 0.63
PHYKPL rs146105181 T/C (N88D) 5:178230016 0.2 2.15x10-20 1.46
PCDH8 rs5030685 A/G (V743A)  13:52846209 0.3 9.92x10-20 2.72
SELE rs5361 T/G (S149R) 1:1169731919 3.3 2.49x10-17 0.95
MOV10L1 rs760749 A/C (I454L) 22:50117257 27.8 2.97x10-17 1.02
HHLA1 rs75623295 C/G (T90R) 8:132098893 2.9 1.23x10-16 0.80
TUBB1 rs6070697 G/A (R307H) 20:59024347 12.1 2.17x10-16 0.92
ZNF708 rs504280 C/T (R66Q) 19:21294577 7.4 2.16x10-15 0.96
TICRR rs79501973 G/A (V1373I) 15:89624427 14.7 2.51x10-15 0.97
ADNP rs148496595 C/G (D924E) 20:50891942 0.3 2.71x10-14 0.68
FCAR rs11666735 G/A (D113N) 19:54885501 3.2 3.10x10-14 1.03
 rs2823962 G/A 21:16673913 32.8 7.80x10-14 0.93
EGFLAM rs1465567 T/C (W229R) 5:38370435 25.1 5.92x10-13 1.19
 rs1480347 G/A 8:20489946 17.3 3.49x10-12 1.07
UBE4B rs180983516 G/A (R331H) 1:10106379 0.8 4.50x10-12 0.60
 rs448705 A/G 8:17837193 12.4 5.42x10-12 1.01
 rs11970286 C/T 6:118359211 17.3 1.38x10-11 0.90
 rs10047727 T/C 13:21743051 42.7 6.67x10-10 0.90
 rs507856 C/T 3:161736158 38.3 7.71x10-9 0.93
SLC1A6 rs7253812 C/A 19:14982691 26.7 9.43x10-9 0.99
FGB rs1800789 G/A 4:154561591 13.3 1.86x10-8 0.99
SLC9A4 rs1014286 A/G (S784G) 2:102532641 43.9 1.90x10-8 1.13
HECTD4 rs2074356 C/T 12:112207597 25.4 2.22x10-8 1.03
PKD1L1 rs66755489 G/A (P2021L) 7:47835032 2.9 2.50x10-8 1.16
CAMSAP1 rs201291561 T/C (N1062S) 9:135821476 0.2 3.04x10-8 1.14
C7orf43 rs3800952 C/T (R353Q) 7:100160331 6.3 4.08x10-8 1.08
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factor. No SNP was found to be related to dissecting aortic 
aneurysm (data not shown).
EWASs of true or dissecting aortic aneurysm. We next 
examined the relation of allele frequencies for the total of 
Figure 2. Manhattan plot for P-values of allele frequencies in the exome-wide association study (EWAS) of aortic aneurysm. The P-values (y-axis) are shown 
as -log10(P) with respect to the physical chromosomal position of the corresponding single nucleotide polymorphism (SNP) (x-axis). The three SNPs ultimately 
found to be significantly associated with true aortic aneurysm (EGFLAM, SPATC1L) or dissecting aneurysm (RNASE13) are indicated.
Table II. Continued.
  Nucleotide
  (amino acid) Chromosome: MAF P-value Allele
Gene dbSNP substitutiona position (%) (allele) OR
ZNF671 rs3746207 G/A (A149V) 19:57721640 12.6 5.90x10-8 0.99
RIN3 rs7150931 T/C 14:92671696 46.2 1.26x10-7 1.03
 rs10805579 G/A 5:19127418 10.5 1.48x10-7 1.03
 rs12546220 T/C 8:69461493 29.1 1.82x10-7 0.96
DRD2 rs12363125 C/T 11:113415194 6.2 1.89x10-7 0.88
MTUS2 rs17571410 G/A 13:29007481 41.4 2.35x10-7 0.91
GALNTL5 rs11766982 A/G 7:151996417 27.6 2.56x10-7 1.05
POLE rs5745022 C/T 12:132632393 20.6 2.82x10-7 0.96
CHAT rs3810947 A/G 10:49613197 43.0 3.19x10-7 0.97
LILRB5 rs117421142 A/G (I420T) 19:54252383 1.0 1.16x10-6 1.29
Allele frequencies were analyzed with Fisher's exact test. aMajor allele/minor allele. MAF, minor allele frequency; OR, odds ratio.
Table III. Correlation of single nucleotide polymorphisms (SNPs) to aortic aneurysm as determined by multivariable logistic 
regression analysis.
 Dominant Recessive Additive 1 Additive 2
 ------------------------------------------------ ----------------------------------------- ----------------------------------------------- ----------------------------------
  P-value OR P-value OR P-value OR P-value OR
SNP   (95% CI)  (95% CI)  (95% CI)  (95% CI)
rs143881017 C/T (R140H) 0.0208 3.00 (1.20-6.80) 0.9665  0.0207 3.00 (1.20-6.79) 0.9667
rs5751416 G/A 0.0351 0.79 (0.63-0.98) 0.2034  0.0697  0.1055
rs142154818 G/A (T1062M) 0.0486 1.94 (1.00-3.50) 0.7044  0.0452 1.97 (1.02-3.54) 0.7078
rs13118 T/A 0.0415 1.32 (1.01-1.71) 0.4182  0.0245 1.37 (1.04-1.78) 0.4879
rs5030685 A/G (V743A)  0.0293 2.94 (1.13-6.76) 0.6067  0.0227 3.12 (1.19-7.22) 0.6090
rs1465567 T/C (W229R) 0.0004 1.49 (1.19-1.85) 0.6932  0.0004 1.51 (1.20-1.90) 0.2807
rs7253812 C/A 0.0834  0.0543  0.0189 1.31 (1.05-1.65) 0.1650
rs7150931 T/C 0.5033  0.0224 1.36 (1.04-1.75) 0.9225  0.0586
Multivariable logistic regression analysis was performed with adjustment for age, gender and the prevalence of hypertension. Based on Bonferroni's 
correction, a P-value of <2.12x10-4 (0.05/236) was considered statistically significant. OR, odds ratio; CI, confidence interval.
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41,432 SNPs to true or dissecting aortic aneurysm separately 
with the use of Fisher's exact test. After Bonferroni's correc-
tion, 45 or 19 SNPs were found to be significantly (P<1.21x10-6) 
associated with true (Table V) or dissecting (Table VI) aortic 
aneurysm, respectively. The genotype distributions of these 
SNPs were in Hardy-Weinberg equilibrium (P>0.001) both 
among patients with true or dissecting aortic aneurysm and 
among control individuals (data not shown).
Multivariable logistic regression analysis of the correlation of 
SNPs to true or dissecting aortic aneurysm. The corrrelation 
of the 45 identified SNPs to true aortic aneurysm was exam-
ined further by multivariable logistic regression analysis with 
adjustment for age, gender and the prevalence of hypertension. 
Among these SNPs, rs113710653 [C/T (E231K)] of the sper-
matogenesis and centriole-associated 1-like gene (SPATC1L) 
was significantly [P<2.78x10-4 (0.05/180)] associated with 
true aortic aneurysm, with the minor T allele representing 
a risk factor for this condition (Table VII). The correlation 
of the 19 identified SNPs to dissecting aortic aneurysm was 
also further examined by multivariable logistic regression 
analysis with adjustment for age, gender and the prevalence 
of hypertension. The SNP rs143881017 [C/T (R140H)] of 
the ribonuclease A family member 13 gene (RNASE13) was 
significantly [P<6.58x10-4 (0.05/76)] associated with dissecting 
aortic aneurysm, with the minor T allele representing a risk 
factor for this condition (Table VII).
Correlation of SNPs to intermediate phenotypes of aortic 
aneurysm. Finally, we examined the correlation of three 
SNPs (rs1465567, rs113710653 and rs143881017) to inter-
mediate phenotypes (hypertension, diabetes mellitus, 
hypertriglyceridemia, hypo-HDL-cholesterolemia, hyper-
LDL-cholesterolemia, chronic kidney disease, obesity and 
hyperuricemia) of aortic aneurysm. No SNP was found to be 
significantly [P<0.0021 (0.05/24)] associated with interme-
diate phenotypes (data not shown).
Discussion
True and dissecting aneurysms of the aorta develop as a result 
of progressive weakening of the vessel wall. They are associ-
ated with characteristic histological features including medial 
degeneration, which involves degeneration and fragmentation 
of elastic fibers as well as loss of smooth muscle cells and an 
accumulation of basophilic ground substances (19). In the 
present study, we showed that rs1465567 [T/C (W229R)] of 
EGFLAM and rs113710653 [C/T (E231K)] of SPATC1L were 
significantly associated with true aortic aneurysm, whereas 
rs143881017 [C/T (R140H)] of RNASE13 was significantly 
associated with dissecting aortic aneurysm, in Japanese indi-
viduals. The minor alleles of these SNPs were all risk factors 
for these conditions.
The EGFLAM is located at chromosomal region 
5p13.2-p13.1 (NCBI Gene, https://www.ncbi.nlm.nih.gov/gene) 
and is expressed in various tissues and organs including vascular 
smooth muscle (The Human Protein Atlas, http://www.protein-
atlas.org). EGFLAM is an extracellular matrix-like protein that 
colocalizes with both dystrophin and dystroglycan to the synaptic 
cleft of the photoreceptor ribbon synapse in the retina and which 
directly interacts with dystroglycan. It plays an important role 
in interactions between the photoreceptor ribbon synapse and 
bipolar dendrites (20,21), and it is implicated in defective photo-
receptor synaptic function associated with congenital muscular 
dystrophies such as muscle-eye-brain disease caused by defec-
tive glycosylation of α-dystroglycan (22). A genome-wide 
pharmacogenomics study identified EGFLAM as a potential 
susceptibility locus for citalopram-induced side effects (23). We 
have now shown that rs1465567 [T/C (W229R)] of EGFLAM 
was significantly associated with true aortic aneurysm, with 
the minor C allele representing a risk factor for this condition, 
although the molecular mechanism underlying this association 
remains unclear.
The SPATC1L is located at chromosomal region 
21q22.3 (NCBI Gene) and is expressed in various tissues 
Table IV. Correlation of single nucleotide polymorphisms (SNPs) to true aortic aneurysm as determined by multivariable logistic 
regression analysis.
 Dominant Recessive Additive 1 Additive 2
 -------------------------------------------------- ------------------------------------------------- -------------------------------------------------- ------------------------------------
   OR  OR  OR  OR
SNP  P-value (95% CI) P-value (95% CI) P-value (95% CI) P-value (95% CI)
rs143881017 C/T (R140H) 0.2899  ND  0.2899  ND
rs5751416 G/A 0.0448 0.73 (0.54-0.99) 0.1221  0.1030  0.0663
rs142154818 G/A (T1062M) 0.2214  0.8209  0.2154  0.8231
rs13118 T/A 0.0253 1.51 (1.05-2.14) 0.6076  0.0167 1.57 (1.09-2.23) 0.6967
rs5030685 A/G (V743A) 0.0779  0.7314  0.0667  0.7333
rs1465567 T/C (W229R) 0.0014 1.63 (1.21-2.21) 0.6670  0.0014 1.66 (1.22-2.27) 0.2911
rs7253812 C/A 0.0122 1.47 (1.09-1.99) 0.2265  0.0032 1.60 (1.17-2.18) 0.5864
rs7150931 T/C 0.7329  0.0431 1.45 (1.01-2.04) 0.2737  0.2350
Multivariable logistic regression analysis was performed with adjustment for age, gender and the prevalence of hypertension. Based on 
Bonferroni's correction, P-values of <0.0016 (0.05/32) were considered statistically significant and are shown in bold. OR, odds ratio; CI, con-
fidence interval; ND, not determined.
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Table V. The 45 single nucleotide polymorphisms (SNPs) significantly (P<1.21x10-6) associated with true aortic aneurysm in an 
exome-wide association study (EWAS).
  Nucleotide
  (amino acid) Chromosome: MAF P-value Allele
Gene dbSNP substitutiona position (%) (allele) OR
KIAA1217 rs10828663 G/A (A807T) 10:24524525 10.4 6.87x10-94 1.14
NRAP rs79461687 G/T (H1246Q) 10:113606247 1.3 1.58x10-90 1.67
OR5W2 rs75634103 G/A 11:55914523 10.4 4.84x10-81 1.17
ATAD5 rs11657270 T/C (Y1419H) 17:30887369 18.1 9.29x10-70 0.98
 rs9683944 A/G 4:137512008 10.8 1.65x10-56 0.83
TMPRSS3 rs928302 C/T (V53I) 21:42389975 27.6 1.34x10-52 0.99
ZNF804B rs6963781 A/G (M1105V) 7:89336295 5.1 6.67x10-47 1.01
ZNF474 rs201335566 G/A (R253Q) 5:122152748 0.5 5.79x10-42 0.84
LOC100506679 rs5751416 G/A 22:43036820 26.3 2.46x10-26 0.71
ARHGEF28 rs536568 A/C 5:73935841 45.8 3.10x10-23 1.03
RALGAPA2 rs142962992 G/C (E1676D) 20:20505435 0.9 8.85x10-23 0.72
LYSMD1 rs79024247 G/T (Q150K) 1:151160974 5.2 7.43x10-21 0.88
CNGA1 rs192912733 C/T (R493Q) 4:47937223 0.7 8.13x10-21 1.17
MOV10L1 rs760749 A/C (I454L) 22:50117257 27.8 1.23x10-20 1.18
HLA-DMB rs151719 A/G 6:32936123 25.7 1.96x10-19 1.17
TUBB1 rs6070697 G/A (R307H) 20:59024347 12.1 3.20x10-18 0.97
 rs3135365 T/G 6:32421478 18.9 3.94x10-17 0.83
CCDC33 rs1484214 A/C 15:74288732 49.3 6.60x10-17 1.09
ZNF708 rs504280 C/T (R66Q) 19:21294577 7.4 3.03x10-15 0.98
 rs2823962 G/A 21:16673913 32.8 3.36x10-14 0.97
SGCZ rs1037934 G/A 8:14399065 9.0 3.44x10-13 1.22
DUOX1 rs199549867 A/T (R569S) 15:45141997 0.2 1.58x10-10 0.81
CTSC rs3888798 T/C (I453V) 11:88294041 16.5 3.21x10-10 1.06
C10orf128 rs118189413 C/G (H67D) 10:49166908 6.3 4.04x10-10 0.84
OR5V1 rs9405124 A/G  6:29401036 19.9 4.15x10-10 0.98
UBAP2L rs143080179 T/C (S641P) 1:154255163 1.3 4.20x10-10 0.66
CAMSAP1 rs201291561 T/C (N1062S) 9:135821476 0.2 5.67x10-10 1.87
TICRR rs79501973 G/A (V1373I) 15:89624427 14.7 7.76x10-10 1.04
NCAM1 rs7111410 C/T 11:113178565 15.9 2.63x10-9 0.80
IRGQ rs3817 C/A 19:43586043 47.7 3.30x10-9 0.92
SSPO rs191064068 G/A (R209H) 7:149777738 1.1 2.35x10-8 1.67
SLC9A4 rs1014286 A/G (S784G) 2:102532641 43.9 2.84x10-8 1.11
 rs2138852 A/G 17:29376331 2.5 2.92x10-8 0.77
SPATC1L rs113710653 C/T (E231K) 21:46161921 1.9 3.91x10-8 7.39
DRD2 rs12363125 C/T 11:113415194 6.2 4.99x10-8 0.87
CCT5 rs201280643 C/G (S373C) 5:10262584 0.4 7.04x10-8 0.99
AXDND1 rs41267592 C/T (T627M) 1:179468524 0.3 7.85x10-8 1.03
 rs507856 C/T 3:161736158 38.3 1.10x10-7 1.02
 rs962040 A/G 8:15454369 30.1 1.21x10-7 0.96
 rs11970286 C/T 6:118359211 17.3 1.60x10-7 0.83
NINL rs199671123 C/T (A796T) 20:25476905 0.2 2.45x10-7 0.85
 rs12531488 C/T 7:145194993 16.0 7.91x10-7 1.14
MROH7 rs143029488 G/C (A1313P) 1:54710152 0.8 1.05x10-6 1.34
AFAP1 rs28406288 G/C (C403S) 4:7800500 0.1 1.10x10-6 ND
GALM rs6741892 A/T (N190Y) 2:38689828 20.1 1.12x10-6 0.93
Allele frequencies were analyzed with Fisher's exact test. aMajor allele/minor allele. MAF, minor allele frequency; OR, odds ratio; ND, not 
determined.
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and organs including vascular smooth muscle (The Human 
Protein Atlas). SPATC1L is distributed in the cytoplasm, 
nucleus, and perinuclear region of cells, and it translocates 
to the sites of cell-cell junctions in response to stimulation of 
cells with the neuropeptide neurokinin A (24). Expression of 
SPATC1L was also found to modulate the response of cells 
to N-methyl-N '-nitro-N-nitrosoguanidine and may thereby 
protect cells from cell death induced by this DNA-damaging 
agent (25). We demonstrated that rs113710653 [C/T (E231K)] 
of SPATC1L was significantly associated with true aortic 
aneurysm, with the minor T allele representing a risk factor 
for this condition, although the functional relevance of this 
association remains to be elucidated.
RNASE13 is located at chromosomal region 14q11.2 
(NCBI Gene) and is expressed at a high level in the epididymis 
(The Human Protein Atlas). A GWAS showed that an SNP 
Table VI. The 19 single nucleotide polymorphisms (SNPs) significantly (P<1.21x10-6) associated with dissecting aortic aneurysm 
in an exome-wide association study (EWAS).
  Nucleotide
  (amino acid) Chromosome: MAF P-value
Gene dbSNP substitutiona position (%) (allele) OR
ATXN7 rs3774729 G/A (V862M) 3:63996406 46.8 3.81x10-35 0.91
KIAA1217 rs10828663 G/A (A807T) 10:24524525 10.4 1.34x10-27 0.78
RNASE13 rs143881017 C/T (R140H) 14:21033870 0.5 5.12x10-26 4.48
INPP5F rs3736822 A/G (I453V) 10:119806397 1.7 8.50x10-23 0.62
 rs9683944 A/G 4:137512008 10.8 4.61x10-17 1.17
 rs9610342 A/G 22:35734530 30.7 8.20x10-17 0.79
FAM98C rs3745962 C/A (T240K) 19:38405604 16.7 8.99x10-15 0.96
ZNF474 rs201335566 G/A (R253Q) 5:122152748 0.5 1.02x10-12 1.95
 rs3135365 T/G 6:32421478 18.9 1.21x10-12 0.86
DEPDC7 rs34161108 G/A (A192T) 11:33027795 6.2 2.29x10-12 0.74
ARHGEF28 rs536568 A/C 5:73935841 45.8 5.53x10-12 1.04
RALGPS1 rs57728614 G/T (G383C) 9:127196583 9.5 5.73x10-11 0.84
AIM1L rs34370465 C/T (R847H) 1:26344118 23.9 3.63x10-10 1.09
ANXA7 rs3750575 C/T (R419Q) 10:73378933 5.7 4.20x10-10 1.06
AXDND1 rs41267592 C/T (T627M) 1:179468524 0.3 1.77x10-8 ND
 rs2138852 A/G 17:29376331 2.5 1.49x10-7 1.32
CHAT rs78925077 C/G (S119R) 10:49622109 0.5 1.50x10-7 1.93
GPR156 rs902790 A/T (E512D) 3:120167929 4.8 2.24x10-7 0.71
SELE rs5361 T/G (S149R) 1:169731919 3.3 3.58x10-7 0.98
Allele frequencies were analyzed with Fisher's exact test. aMajor allele/minor allele. MAF, minor allele frequency; OR, odds ratio; ND, not 
determined.
Table VII. Relation of single nucleotide polymorphisms (SNPs) to true or dissecting aortic aneurysm as determined by multivari-
able logistic regression analysis.
 Dominant Recessive Additive 1 Additive 2
 --------------------------------------------------- -------------------------------------- --------------------------------------------------- -------------------------------------
   OR  OR  OR  OR
SNP  P-value (95% CI) P-value (95% CI) P-value (95% CI) P-value (95% CI)
True aortic aneurysm
rs113710653 C/T (E231K) 0.0002 5.32 (2.33-11.14) 0.9263  0.0002 5.34 (2.34-11.18) 0.9299
Dissecting aortic aneurysm
rs143881017 C/T (R140H) 0.0006 5.77 (2.25-12.95) 0.9615  0.0006 5.48 (2.26-12.97) 0.9621
Multivariable logistic regression analysis was performed with adjustment for age, gender and the prevalence of hypertension. Based on Bonferroni's 
correction, P-values of <2.78x10-4 (0.05/180) or <6.58x10-4 (0.05/76) were considered statistically significant for true or dissecting aortic aneurysm, 
respectively, and are shown in bold. OR, odds ratio; CI, confidence interval.
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(rs3748348) located in the vicinity of RNASE13 was associ-
ated with executive functioning resilience (26). Gene-based 
analyses also revealed a genome-wide significant association 
between RNASE13 and executive functioning resilience (27). 
We now showed that rs143881017 [C/T (R140H)] of RNASE13 
was significantly associated with dissecting aortic aneurysm, 
with the minor T allele representing a risk factor for this condi-
tion, although the molecular mechanism underpinning this 
association remains unknown.
Previous GWASs identified the SNPs: rs10757278 of 
CDKN2BAS, rs7025486 of DAP2IP, rs1466535 of LRP1, 
rs2118181 of FBN1, rs6511720 of LDLR and rs599839 of 
SORT1 as susceptibility loci for aortic aneurysm (7-12). The 
MAFs of these SNPs were >10%, and the odds ratios were 
0.8-1.8 (5.7-12.28). We now identified three novel loci that may 
confer susceptibility to true or dissecting aortic aneurysm, 
with the odds ratios (MAF, %) of rs1465567 of EGFLAM, 
rs113710653 of SPATC1L, and rs143881017 of RNASE13 
being 1.63 (25.1%), 5.32 (1.9%),and 5.77 (0.5%), respectively. 
Although rs1465567 of EGFLAM was a common variant with 
a small effect size, rs113710653 of SPATC1L and rs143881017 
of RNASE13 were low-frequency variants with moderate to 
large effect sizes.
There are some limitations to the present study: i) Given 
that the number of subjects with aortic aneurysm was rela-
tively small and the results of the study were not replicated, 
our findings will require validation with other independent 
subject panels or in other ethnic groups. ii) It is possible 
that rs1465567 of EGFLAM, rs113710653 of SPATC1L, or 
rs143881017 of RNASE13 is in linkage disequilibrium with 
other polymorphisms in the same gene or in other nearby 
genes that are actually responsible for the development of 
true or dissecting aneurysm. iii) The functional relevance of 
these SNPs to the pathogenesis of true or dissecting aneurysm 
remains to be elucidated.
In conclusion, rs1465567 of EGFLAM and rs113710653 
of SPATC1L may be susceptibility loci for true aortic aneu-
rysm and rs143881017 of RNASE13 may be such a locus 
for dissecting aortic aneurysm in Japanese individuals. 
Determination of genotypes for these SNPs may prove infor-
mative for assessment of the genetic risk for these conditions 
in Japanese individuals.
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